Abstract:2302 Objectives Acetylcholinesterase is an attractive target for anti-Alzheimer’s disease (AD)drug design1. Docking simulation and three- dimensional quantitative structure-actibity relationships (3D-QSAR) analysis were conduced on a series of dual binding site inhibitors of Acetylcholinesterase (AChE).Based on this model, we have designed some new AChEI with good binding affinity and selectivity.As the causes of AD have not been clearly understood ,so the imaging of Acetylcholinesterase Inhibitors(AChEI) with PET and SPECT could provide a useful tool for understanding how alterations of this system are related to depressive illnesses and other psychiatric disorders, as well as to monitor the treatment of depressed patients. Methods Computational methods: The model date set were selected from published lieratures2, 3. The AutoDock1.4.5 tool was used for the study of finding active conformer. 3D-QSAR models were derived on the basis of protonated molecules with pKi values spreading over a range of five logarithmic units. All molecular modeling studies were performed using SYBYL 7.0. Gasteiger-Hueckel charges were calculated for all compounds. Results The CoMFA model generated from steric and electrostatic fields exhibited q2 0.652 , r2 0.917, F139.030, S 0.245, with 68.2% steric and 31.8% electrostatic field contributions. The CoMSIA model for steric , electrostatichydrophobic, H-Donor and H-Acceptor fields yielded q2 0.641 , r2 0.903, F117.941, S 0.264, with 5.8% steric, 19.4% electrostatic and 23.7% hydrophobic, 27.8%H-Donor, 23.2%H-Acceptor field contributions. Conclusions The preliminary experimental and further radiolabelling and in vivo evaluation are in progress. Research Support This work was supported by the Natural Science Foundation of China (No. 20671013)

Evaluation Of Novel Dual Acetyl- And Butyrylcholinesterase Inhibitors As Potential Anti-Alzheimer'S Disease Agents Using Pharmacophore, 3d-Qsar And Molecular Docking Approaches

Design, Synthesis and Biological Evaluation of 2-Styryl-5-hydroxy-4-pyrone Derivatives and Analogues As Multiple Functional Agents with the Potential for the Treatment of Alzheimer's Disease.

Searching for the Multi-Target-Directed Ligands Against Alzheimer’s Disease: Discovery of Quinoxaline-Based Hybrid Compounds with AChE, H3R and BACE 1 Inhibitory Activities

Design, Synthesis, and Biological Evaluation of a New Series of Biphenyl/Bibenzyl Derivatives Functioning As Dual Inhibitors of Acetylcholinesterase and Butyrylcholinesterase

3D-Qsar, Synthesis and in Vitro Evaluation Study on Dual Binding Site Inhibitors of Acetylcholinestrase

Discovery, Structure-Based Modification, In Vitro , In Vivo , and In Silico Exploration of m -Sulfamoyl Benzoamide Derivatives as Selective Butyrylcholinesterase Inhibitors for Treating Alzheimer’s Disease

Discovery, Structure-Based Modification, in Vitro, in Vivo, and in Silico Exploration of M-Sulfamoyl Benzoamide Derivatives As Selective Butyrylcholinesterase Inhibitors for Treating Alzheimer's Disease.

The Structural Basis of DL0410, A Novel Multi-Target Candidate Drug for the Treatment of Alzheimer’s Disease

Design, synthesis, and biological evaluation of aromatic tertiary amine derivatives as selective butyrylcholinesterase inhibitors for the treatment of Alzheimer's disease

Pharmacokinetics, excretion and metabolites analysis of DL0410, a dual‑acting cholinesterase inhibitor and histamine‑3 receptor antagonist.

Discovery of Novel Acetylcholinesterase Inhibitors as Potential Candidates for the Treatment of Alzheimer's Disease

Novel Dual Acetyl- and Butyrylcholinesterase Inhibitors Based on the Pyridyl–Pyridazine Moiety for the Potential Treatment of Alzheimer's Disease

Discovery of Novel Isoflavone Derivatives As AChE/BuChE Dual-Targeted Inhibitors: Synthesis, Biological Evaluation and Molecular Modelling

Discovery and Biological Evaluation of New Selective Acetylcholinesterase Inhibitors with Anti-Aβ Aggregation Activity Through Molecular Docking-Based Virtual Screening.

Design, synthesis and biological evaluation of novel dual inhibitors of acetylcholinesterase and beta-secretase

Identification of novel acetylcholinesterase inhibitors through 3D-QSAR, molecular docking, and molecular dynamics simulation targeting Alzheimer’s disease

Multipotent Ache and Bace-1 Inhibitors for the Treatment of Alzheimer'S Disease: Design, Synthesis and Bio-Analysis of 7-Amino-1,4-dihydro-2h-isoquilin-3-one Derivates

Design, Synthesis, and Biological Evaluation of Dual-Target Inhibitors of Acetylcholinesterase (ache) and Phosphodiesterase 9A (PDE9A) for the Treatment of Alzheimer's Disease

Design, synthesis and biological evaluation of novel pyrazolone derivatives as selective butyrylcholinesterase inhibitors with antioxidant activity against Alzheimer's disease

Design, synthesis and biological evaluation of dual acetylcholinesterase and phosphodiesterase 5A inhibitors in treatment for Alzheimer's disease.

Synthesis and biological evaluation of substituted acetamide derivatives as potential butyrylcholinestrase inhibitors